Securing capital is paramount for biotechnology companies striving for significant development. As the field evolves, a deep knowledge of financial strategies becomes increasingly vital. Venture capitalists often seek firms with a strong portfolio of success and innovative pipeline. To secure the necessary capital, biotech companies must present a